国药现代：拟中选第十一批全国药品集中采购

Core Viewpoint - The company, Guoyao Modern, announced participation in the 11th national centralized procurement organized by the National Organization for Drug Procurement Office, with six out of seven products expected to be selected for procurement, impacting the company's revenue for 2024 [1] Group 1: Procurement Participation - Guoyao Modern and its subsidiaries participated in the 11th batch of national drug centralized procurement [1] - A total of seven products from the company were eligible for this procurement, with six products expected to be selected [1] Group 2: Financial Impact - The total expected sales revenue from the selected products for 2024 is approximately 29,100.71 thousand yuan, accounting for about 2.66% of the company's projected revenue for the year [1] - The product not selected, sodium bicarbonate injection, is projected to have a sales revenue of 743.63 thousand yuan for 2024, representing a low proportion of the overall revenue [1]